|
Cvs Health Corporation (CVS) |
|
|
|
CVS's Net Income Growth by Quarter and Year
Cvs Health's Net Income results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
CVS Net Income (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
IV Quarter |
December |
2,047.00
|
2,300.00
|
1,296.00
|
975.00
|
III Quarter |
September |
2,265.00
|
-3,409.00
|
1,587.00
|
1,219.00
|
II Quarter |
June |
1,914.00
|
2,961.00
|
2,791.00
|
2,986.00
|
I Quarter |
March |
2,142.00
|
2,313.00
|
2,224.00
|
2,012.00
|
FY |
|
8,368.00
|
4,165.00
|
7,898.00
|
7,192.00
|
CVS Net Income fourth quarter 2023 Y/Y Growth Comment |
Cvs Health Corporation reported fall in Net Income in the fourth quarter 2023 by -11% to $ 2,047.00 millions, from the same quarter in 2022. The decline in the fourth quarter 2023 Cvs Health Corporation's Net Income compares unfavorably to the Company's average Net Income increase of 16.85%.
According to the results reported in the fourth quarter 2023, Cvs Health Corporation achieved the best Net Income growth in Pharmacy Services & Retail Drugstore industry. While Cvs Health Corporation' s Net Income decrease of -11% ranks overall at the positon no. 844 in the fourth quarter 2023.
|
CVS Net Income ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
-11 % |
77.47 % |
32.92 % |
-44.09 % |
III Quarter |
September |
- |
- |
30.19 % |
-20.27 % |
II Quarter |
June |
-35.36 % |
6.09 % |
-6.53 % |
54.63 % |
I Quarter |
March |
-7.39 % |
4 % |
10.54 % |
41 % |
FY |
|
100.91 % |
-47.27 % |
9.82 % |
8.46 % |
CVS Net Income (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
-9.62 % |
- |
-18.34 % |
-20.02 % |
III Quarter |
September |
18.34 % |
- |
-43.14 % |
-59.18 % |
II Quarter |
June |
-10.64 % |
28.02 % |
25.49 % |
48.41 % |
I Quarter |
March |
-6.87 % |
78.47 % |
128.1 % |
15.37 % |
FY (Year on Year) |
|
100.91 % |
-47.27 % |
9.82 % |
8.46 % |
Net Income Y/Y Growth Statistics |
High |
Average |
Low |
142.61 % |
16.85 % |
-44.09 % |
(Sep. 30, 2007) |
|
(Dec 31 2020) |
|
Net Income Y/Y Growth Statistics |
High |
Average |
Low |
142.61 % |
16.85 % |
-44.09 % |
(Sep. 30, 2007) |
|
(Dec 31 2020) |
|
Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Cvs Health's Q/Q Net Income Growth
Net Income Q/Q Growth Statistics |
High |
Average |
Low |
155.8 % |
7.06 % |
-69.64 % |
(Dec 31 2017) |
|
|
CVS's IV. Quarter Q/Q Net Income Comment |
In the IV. Quarter 2023 Cvs Health Corporation realized drop in Net Income from the previous quarter by -9.62% to $ 2,047.00 millions, from $ 2,265.00 millions declared a quarter before.
Within Pharmacy Services & Retail Drugstore industry only one company achieved higher sequential Net Income growth. While Cvs Health's Net Income growth quarter on quarter, overall rank is 233. |
|
|
Net Income Q/Q Growth Statistics |
High |
Average |
Low |
155.8 % |
7.06 % |
-69.64 % |
(Dec 31 2017) |
|
|
CVS's IV. Quarter Q/Q Net Income Comment |
In the IV. Quarter 2023 Cvs Health Corporation reported drop in Net Income from the previous quarter by -9.62% to $ 2,047.00 millions, from $ 2,265.00 millions achived a quarter before.
Within Pharmacy Services & Retail Drugstore industry only one company achieved higher sequential Net Income growth. While Cvs Health's Net Income growth quarter on quarter, overall rank is 233. |
|
Cvs Health's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending (Dec 31 2023) |
12 Months Ending (Sep 30 2023) |
12 Months Ending (Jun 30 2023) |
12 Months Ending (Mar 31 2023) |
12 Months Ending (Dec 31 2022) |
Cumulative Net Income 12 Months Ending |
$ 8,368.00 |
$ 8,621.00 |
$ 2,947.00 |
$ 3,994.00 |
$ 4,165.00 |
Y / Y Net Income Growth (TTM) |
100.91 % |
172.73 % |
-63.87 % |
-49.99 % |
-47.27 % |
Year on Year Net Income Growth Overall
Ranking |
# 185 |
# 1813 |
# 274 |
# 353 |
# 716 |
Seqeuential Net Income Change (TTM) |
-2.93 % |
192.53 % |
-26.21 % |
-4.11 % |
31.76 % |
Seq. Net Income Growth (TTM) Overall
Ranking |
# 147 |
# 1833 |
# 1042 |
# 1077 |
# 1046 |
Cumulative Net Income growth
Comment |
Assuming the Cvs Health's fiscal year would have ended in Dec 31 2023, Cvs Health would have reprted above average annual Net Income surge of 100.91% year on year, of $ 8,368 millions. This marks a slow-down of the companys growth trends and from the 172.73% surge in Sep 30 2023. But looking into other companies within Pharmacy Services & Retail Drugstore industry, just one company had higher Net Income growth.
Among companies within the Retail sector 17 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 185, from total ranking in previous quarter at 1813. |
Net Income TTM Q/Q Growth Statistics |
High |
Average |
Low |
172.73 % |
12.8 % |
-109 % |
|
|
|
|
|
Net Income TTM Y/Y Growth Statistics |
High |
Average |
Low |
172.73 % |
12.8 % |
-109 % |
|
|
|
Net Income TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 2 |
Sector |
# 4 |
S&P 500 |
# 147 |
|
Cumulative Net Income growth
Comment |
Assuming the Cvs Health's fiscal year would have ended in Dec 31 2023, Cvs Health would have reprted above average annual Net Income surge of 100.91% year on year, of $ 8,368 millions. This marks a slow-down of the companys growth trends and from the 172.73% surge in Sep 30 2023. But looking into other companies within Pharmacy Services & Retail Drugstore industry, just one company had higherNet Income growth.
Among companies within the Retail sector 17 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 185, from total ranking in previous quarter at 1813. |
Net Income TTM Q/Q Growth Statistics |
High |
Average |
Low |
172.73 % |
12.8 % |
-109 % |
|
|
|
Net Income TTM Y/Y Growth Statistics |
High |
Average |
Low |
172.73 % |
12.8 % |
-109 % |
|
|
|
Net Income TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 2 |
Sector |
# 4 |
S&P 500 |
# 147 |
|